Lumida
/IDYA
⌘K
IDEAYA Biosciences Inc

IDEAYA Biosciences Inc

IDYA
$37.59USD+0.37%+0.14 today

MARKET CAP

3.6B

P/E (TTM)

FWD P/E

DAY RANGE

$37 – $38

52W RANGE

$24
$43

AI Summary

Stalk
StalkMedium

IDYA has printed a Bullish Exhaustion candle at recent highs amid extreme overbought conditions, signaling waning upside momentum. Despite a Stage 2 advancing structure with price above rising EMAs and an uptrend, short-term weakness into the 9/21 EMA zone deters immediate entry. Medium-term bias remains bullish, but deferred pullbacks into the rising EMA support zone should be monitored for acceptance before engaging.

  • Phase 2/3 darovasertib + crizotinib trial achieved 6.9-month median PFS
  • Generated $8.9M in Q2 collaboration revenue
  • Reported Q2 net loss of $112.5M, wider than Q1
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income